Search result
EKFS verleiht erstmalig Publikationspreise an drei von ihr geförderte Nachwuchswissenschaftler
Bad Homburg v.d. Höhe, 3. September 2020 – Drei von der Else Kröner-Fresenius-Stiftung (EKFS) geförderte Nachwuchswissenschaftler werden als besondere Anerkennung für eine herausragende Entdeckung mit dem Publikationspreis der Stiftung ausgezeichnet.
Aging and disease: translational analysis of therapeutic interventions (AntiAge)”
Institution: Jena University Hospital
Applicant: Prof. Dr. med. Otto W. Witte
Graduate School “Else Kröner-Promotionskolleg – Jena School for Ageing Medicine (JSAM)”
Institution: Universitätsklinikum Jena (UKJ)
Applicant: Prof. Dr. med. Otto W. Witte
Phosphoproteom-Dynamics
Institution: Medizinische Fakultät der TU Dresden
Applicants: Ali El-Armouche, Martin Bornhäuser
Molecular retargeting of virotherapy-induced antibodies for induction of antibody-dependent tumor cytotoxicity
Institution: Dept. Gastroenterology, Hepatology and Endocrinology,Hannover Medical School
Applicant: Prof. Dr. Florian Kühnel
Renal impairment as a complication of systemic diseases
Institution: Medical Center - University of Freiburg, Department of Medicine IV (Nephrology)
Applicant: Prof. Dr. Gerd Walz
Scientific Funding
Advancing Research - The Else Kröner-Fresenius-Stiftung (foundation) views it as its mission to increase knowledge revolving around the causes, diagnosis and therapy of diseases to the benefit of mankind.
Funding Lines
The guiding principles of medical-scientific funding are scientific excellence and support of young medical scientists.
Else Kröner Excellence Fellowships
The Else Kröner Excellence Fellowships grant clinicians at senior consultant level a two-year leave of absence for an intensive research phase.
Checking back: What is Prof. Dr. Kilian Schober doing these days?
Prof. Dr. Kilian Schober was recently honored with the Life Sciences Bridge Award and appointed to a Heisenberg professorship. In his research he devotes himself to the immunity of human T-cells toward developing effective therapies against infectious diseases, cancers and autoimmunity.